OMEROS CORP Accrued Income Taxes, Current
OMEROS CORP (OMER) had Accrued Income Taxes, Current of $656.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2026-08-12
- 2026-06-30: Accrued Income Taxes, Current $656.00K.
- 2026-03-31: Accrued Income Taxes, Current $1.15M.
- 2025-12-31: Accrued Income Taxes, Current $1.15M.
- 2024-12-31: Accrued Income Taxes, Current $55.00K.
| Period end | Accrued Income Taxes, Current | Accrued Income Taxes, Current as first filed |
|---|---|---|
| 2026-06-30 | $656.00K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $1.15M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $1.15M 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $55.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $807.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $1.54M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $1.18M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $316.00K 10-Q · filed 2024-11-13 | |
| 2023-09-30 | $1.23M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.23M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $4.87M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $5.54M 10-K · filed 2024-04-01 | $4.87M 10-K · filed 2023-03-13 |
| 2021-12-31 | $338.00K 10-K · filed 2023-03-13 | $300.00K 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |